HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

VDA-P protocol

chemotherapy protocol consisting of above 2 cpds; has been used in therapy of lung cancer

Also Known As:

PV protocol; VP regimen

Networked: 5 relevant articles (0 outcomes, 0 trials/studies)

Therapy Context: Research Results

Therapeutics: 1158551
- Drug Therapy: 293145
  - Combination Drug Therapy: 12066
    - Antineoplastic Combined Chemotherapy Protocols: 35
      - VDA-P protocol: 5
  - Antineoplastic Protocols: 55
    - Antineoplastic Combined Chemotherapy Protocols: 35
      - VDA-P protocol: 5
- Clinical Protocols
  - Antineoplastic Protocols: 55
    - Antineoplastic Combined Chemotherapy Protocols: 35
      - VDA-P protocol: 5
Inorganic Chemicals: 9
Heterocyclic Compounds: 198
- Alkaloids: 5398
  - Indole Alkaloids: 200
    - Secologanin Tryptamine Alkaloids: 81
      - Vinca Alkaloids: 463
        Vindesine: 836
        VDA-P protocol: 5
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Indoles: 200
      - Indole Alkaloids: 200
        Secologanin Tryptamine Alkaloids: 81
        Vinca Alkaloids: 463
        Vindesine: 836
        VDA-P protocol: 5
    - Indolizines: 3
      - Indolizidines: 2
        Indole Alkaloids: 200
        Secologanin Tryptamine Alkaloids: 81
        Vinca Alkaloids: 463
        Vindesine: 836
        VDA-P protocol: 5

Experts

1.	Gaspar, Jaymee L: 1 article (08/2019)
2.	Rosene, Audrey C: 1 article (08/2019)
3.	Gao, Xiao-Ning: 1 article (12/2015)
4.	Guo, Yue-Lu: 1 article (12/2015)
5.	Han, Xiao-Pin: 1 article (12/2015)
6.	Jin, Xiang-Shu: 1 article (12/2015)
7.	Jing, Yu: 1 article (12/2015)
8.	Liu, Kui: 1 article (12/2015)
9.	Yao, Zi-Long: 1 article (12/2015)
10.	Yu, Li: 1 article (12/2015)

Related Diseases

1.	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 04/01/1999 - "He was given a diagnosis of acute lymphoblastic leukemia and treated with an Ad-VP regimen, which resulted in complete remission. "
2.	Neutropenia 12/01/2015 - "VP regimen would be stopped when neutropenia lasted for 1 week or complicated with infection, fever, etc. Therapeutic effects were assessed by bone marrow morphology and quantitative analysis of BCR/ABL:ABL at the 28(th) - 33(rd) day. "
3.	Neoplasms (Cancer) 01/01/1995 - "These data suggest that V is an active agent in NSCLC and that the VP regimen may yield results comparable to other cisplatin combinations for treatment of these tumors."
4.	Infections 12/01/2015 - "VP regimen would be stopped when neutropenia lasted for 1 week or complicated with infection, fever, etc. Therapeutic effects were assessed by bone marrow morphology and quantitative analysis of BCR/ABL:ABL at the 28(th) - 33(rd) day. "
5.	Hepatitis C 08/01/2019 - "A 62-year-old male with a past medical history of hepatitis C genotype 1a and stable warfarin dose history was initiated on a concomitant Viekira Pak® (VP) regimen containing ritonavir. "

Related Drugs and Biologics

1.	Therapeutic Uses
2.	Ritonavir (Norvir)
3.	Warfarin (Coumadin)
4.	Cisplatin (Platino)